Back to top
more

Medpace (MEDP)

(Real Time Quote from BATS)

$429.31 USD

429.31
31,020

+8.00 (1.90%)

Updated Jul 22, 2024 11:04 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 27% (67 out of 250)

Industry: Medical Services

Better trading starts here.

Zacks News

BioLife (BLFS) Progresses in Cell & Gene Therapy With CryoCase

BioLife's (BLFS) latest product, CryoCase, is compatible with various downstream processing systems, including its own Signata CT-5.

Charles River (CRL) Launches Viral Vector Tech Transfer Program

Charles River's (CRL) new Fast Track and Modular frameworks facilitate product development continuity via accelerated process transfer to its viral vector Center of Excellence.

QIAGEN (QGEN) Develops Test for Research and CDx Application

QIAGEN's (QGEN) next-generation sequencing test aims to aid personalized medicine research in solid tumor types, including ovarian cancer, and improve decentralized testing capabilities.

Here's Why You Should Retain Globus Medical (GMED) Stock Now

Investors are optimistic about Globus Medical (GMED) led by strong musculoskeletal prospects and raised guidance.

Is First Trust Health Care AlphaDEX ETF (FXH) a Strong ETF Right Now?

Smart Beta ETF report for FXH

Zimmer Biomet (ZBH) Unlocks Growth Plan for Future Success

Zimmer Biomet (ZBH) outlines a path for compelling and long-term topline growth, improved operational profitability, and increased free cash flow generation.

SenesTech (SNES) to Gain Market With Evolve's Launch on Amazon

SenesTech (SNES) looks to leverage the convenience and reach of e-commerce to expand its market share.

Tandem Diabetes (TNDM) Connects Mobi Pump With Dexcom G7 Sensor

Tandem Diabetes' (TNDM) Mobi insulin pump is now compatible with Dexcom G7 CGM.

Reasons to Hold Charles River (CRL) in Your Portfolio Now

Investors remain optimistic about Charles River (CRL), owing to its acquisitions, thriving DSA segment and financial stability.

Here is Why Growth Investors Should Buy Medpace (MEDP) Now

Medpace (MEDP) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Inspira Technologies' (IINN) ART100 Gets FDA 510(k) Grant

Inspira Technologies' (IINN) ART100 recent approval highlights the company's innovative advancements in medical technology.

Exact Sciences (EXAS) Witnesses Rising Expenses, Competition

Exact Sciences (EXAS) has numerous competitors, given the large market for colorectal cancer screening.

Medpace (MEDP) Rises Higher Than Market: Key Facts

The latest trading day saw Medpace (MEDP) settling at $390.81, representing a +0.07% change from its previous close.

Exact Sciences (EXAS) to Showcase Favorable Research Outcome

Exact Sciences' (EXAS) latest study research result shows commitment to innovation and strategies that expand access to effective cancer screening and diagnostic tools for patients.

Here's Why Investors Should Retain ICON (ICLR) Stock Now

Investors remain optimistic about ICON (ICLR) due to its impressive strategic pacts and stable solvency.

Stereotaxis (STXS) Gets CE Recertification for Approved Products

Stereotaxis' (STXS) receives updated EU Quality Management System Certificate, which demonstrates compliance with MDR.

Here's Why You Should Buy Boston Scientific (BSX) Stock Now

Investors continue to be optimistic about Boston Scientific (BSX) due to its geographical expansions and impressive acquisitions.

Charles River (CRL) Banks on RMS Growth Amid Competition

Charles River's (CRL) RMS arm sees lesser impact on demand than other life science sectors despite macroeconomic challenges in China.

Here's Why You Should Retain Edward Lifesciences (EW) for Now

Investors are optimistic about Edward Lifesciences (EW), led by the strong performance of its SAPIEN 3 Ultra RESILIA platform and strong solvency.

Zacks Market Edge Highlights: Wingstop, Super Micro Computer, Medpace, Him & Hers Health and Vita Coco

Wingstop, Super Micro Computer, Medpace, Him & Hers Health and Vita Coco are part of the Zacks Market Edge blog.

Medtronic's (MDT) OmniaSecure Lead Favored in the LEADR Trial

Medtronic's (MDT) OmniaSecure defibrillation lead demonstrates reliable performance in the LEADR Pivotal trial.

Reasons to Include Alcon (ALC) in Your Portfolio Right Now

New product launches and strong solvency bode well for Alcon (ALC).

Tracey Ryniec headshot

5 Top Ranked Strong Buy Growth Stocks for 2024

Get double digit earnings growth this year.

Centene (CNC), Cityblock Partner to Enhance Value-Based Care

Centene (CNC) collaborates with Cityblock to provide comprehensive care services to Central Florida's Medicaid members.

Medtronic (MDT) Q4 Earnings Beat Estimates, Margins Down

Growth across Cranial & Spinal Technologies, Diabetes, Cardiac Pacing and Surgical businesses contributes to Medtronic's (MDT) Q4 revenues.